October 2009 - Gene Therapy PI You Tube! Joe Kornegay was interviewed at the American College of Veterinary Internal Medicine (ACVIM) in Seattle last June. The context within ACVIM is that their work is an example of “One Medicine” or “Comparative Medicine” intended to advance the understanding of diseases in both humans and animals.
http://www.youtube.com/watch?v=M2VLKKJTIsw
August 2009 - The UNC Gene Therapy Center was featured in the August 30 edition of Parade magazine. Parade published the article in anticipation of the annual Jerry Lewis Muscular Dystrophy Association Telethon, which commences Sunday, September 6, 2009.
May 2009 - Dr. Samulski's "Incredible Journey" interview with the RENCI Center
April 2009 - The UNC Gene Therapy Center is featured in the April 26 edition of The News & Observer
March 2009 - The UNC Senator Paul D. Wellstone Center of Excellence for Muscular Dystrophy Research held its inauguration event on March 2, 2009. Distinguished guests included Rep. David Price and Chancellor Holden Thorpe.
Click here for the UNC press release.
October 2008 - UNC Gene Therapy Center has been awarded a five-year, $7 million grant to establish a muscular dystrophy research center named in honor of the late Sen. Paul D. Wellstone of Minnesota, who earned his undergraduate and doctoral degrees at UNC. Click here for the official press release
June 2008 - Jude Samulski, Director, has received the inaugural Oustanding Achievement Award given by the American Society of Gene Therapy. The award recognizes an active member of the society who has achieved a pioneering research success, a specific high-impact accomplishment or a lifetime of significant contributions to the field of gene therapy. Click here for the official press release.
March 2006 - The first clinical trial for Duchenne Muscular Dystrophy begins, utilizing AAV vectors developed and produced in Dr. Samulski's laboratory. Click here for more information.
January 2005 - Dr. Samulski is interviewed for the MDA's Quest Magazine - "Bridge Over Troubled Waters: Crossing to Safety and Efficacy in Gene Therapy is Current Challenge"
